Li Xu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 26

Top Topics

Hepatitis B Virus

Prognostic Factors

Top Venues

Journal of hepatocellular carcinoma

Proceedings of the National Academy of Sciences of the United States of America

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Shufeng Luo, Huiling Lin, Chong Wu, Lan Zhu, Qiaomin Hua, Yulan Weng, Lu Wang, Xiaoli Fan, Kai-Bo Zhao, Gaoteng Liu, Yuting Wang, Hai-Tian Chen, Li Xu, Limin Zheng
Cholinergic macrophages promote the resolution of peritoneal inflammation. Proceedings of the National Academy of Sciences of the United States of America 121 (27) (2024)
Yi-Xiang Gan, Zi-Liang Yang, Yang-Xun Pan, Li-Ying Ou-Yang, Yu-Hao Tang, Yao-Jun Zhang, Min-Shan Chen, Li Xu
Change of indocyanine green clearance ability and liver function after transcatheter intra-arterial therapies and its impact on outcomes of resectable hepatocellular carcinoma: a retrospective cohort study. International journal of surgery (London, England) 110 (5) (2024)
Shufeng Luo, Huiling Lin, Chong Wu, Lan Zhu, Qiaomin Hua, Yulan Weng, Lu Wang, Xiaoli Fan, Kai-Bo Zhao, Gaoteng Liu, Yuting Wang, Hai-Tian Chen, Li Xu, Limin Zheng
Cholinergic macrophages promote the resolution of peritoneal inflammation. Proceedings of the National Academy of Sciences of the United States of America 121 (27) (2024)
Yi-Xiang Gan, Zi-Liang Yang, Yang-Xun Pan, Li-Ying Ou-Yang, Yu-Hao Tang, Yao-Jun Zhang, Min-Shan Chen, Li Xu
Change of indocyanine green clearance ability and liver function after transcatheter intra-arterial therapies and its impact on outcomes of resectable hepatocellular carcinoma: a retrospective cohort study. International journal of surgery (London, England) 110 (5) (2024)
Wenxuan Li, Zhikai Zheng, Jiongliang Wang, Tianqing Wu, Juncheng Wang, Yang-Xun Pan, Jin-Bin Chen, Dandan Hu, Li Xu, Yao-Jun Zhang, Minshan Chen, Zhongguo Zhou
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy. Journal of hepatocellular carcinoma 11 (2024)
Shufeng Luo, Huiling Lin, Chong Wu, Lan Zhu, Qiaomin Hua, Yulan Weng, Lu Wang, Xiaoli Fan, Kai-Bo Zhao, Gaoteng Liu, Yuting Wang, Hai-Tian Chen, Li Xu, Limin Zheng
Cholinergic macrophages promote the resolution of peritoneal inflammation. Proceedings of the National Academy of Sciences of the United States of America 121 (27) (2024)
Wenxuan Li, Zhikai Zheng, Jiongliang Wang, Tianqing Wu, Juncheng Wang, Yang-Xun Pan, Jin-Bin Chen, Dandan Hu, Li Xu, Yao-Jun Zhang, Minshan Chen, Zhongguo Zhou
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy. Journal of hepatocellular carcinoma 11 (2024)
MinKe He, YeXing Huang, Zefeng Du, ZhiCheng Lai, Hanyue Ouyang, JingXian Shen, DongSheng Wen, Qi-Jiong Li, Yao-Jun Zhang, Wei Wei, MinShan Chen, Li Xu, Anna Kan, Ming Shi
Lenvatinib, toripalimab plus FOLFOX chemotherapy in hepatocellular carcinoma patients with extrahepatic metastasis: A biomolecular exploratory, phase II trial (LTSC). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Zhikai Zheng, Jiongliang Wang, Tianqing Wu, Minrui He, Juncheng Wang, Yang-Xun Pan, Jin-Bin Chen, Dandan Hu, Li Xu, Yao-Jun Zhang, Minshan Chen, Zhongguo Zhou
Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy. Journal of hepatocellular carcinoma 10 (2023)
Tianqing Wu, Zhikai Zheng, Jiongliang Wang, Minrui He, Juncheng Wang, Yang-Xun Pan, Jin-Bin Chen, Dandan Hu, Yao-Jun Zhang, Li Xu, Minshan Chen, Zhongguo Zhou
Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy. Journal of hepatocellular carcinoma 10 (2023)
Yizhen Fu, Xia Li, Zhenyun Yang, Shaoqiang Li, Yang-Xun Pan, Jin-Bin Chen, Juncheng Wang, Dandan Hu, Zhong-Guo Zhou, Li Xu, Minshan Chen, Yao-Jun Zhang
A risk-based postresection follow-up strategy for hepatocellular carcinoma patients. Cancer 129 (4) (2022)
Zhenyun Yang, Deyao Zhang, Huilan Zeng, Yizhen Fu, Zi-Li Hu, Yang-Xun Pan, Jin-Bin Chen, Juncheng Wang, Yao-Jun Zhang, Zhongguo Zhou, Li Xu, Dandan Hu, Minshan Chen
Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma. Journal of inflammation research 15 (2022)
Yizhen Fu, Xia Li, Zhenyun Yang, Shaoqiang Li, Yang-Xun Pan, Jin-Bin Chen, Juncheng Wang, Dandan Hu, Zhong-Guo Zhou, Li Xu, Minshan Chen, Yao-Jun Zhang
A risk-based postresection follow-up strategy for hepatocellular carcinoma patients. Cancer 129 (4) (2022)
Jun-Cheng Wang, Dong-Ping Chen, Shi-Xun Lu, Jin-Bin Chen, Yuan Wei, Xue-Chao Liu, Yu-Hao Tang, Rong-Xin Zhang, Jian-Cong Chen, Anna Kan, Li Xu, Yao-Jun Zhang, Jiajie Hou, Dong-Ming Kuang, Min-Shan Chen, Zhong-Guo Zhou
PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma. Cancer research 82 (18) (2022)
Yizhen Fu, Xia Li, Zhenyun Yang, Shaoqiang Li, Yang-Xun Pan, Jin-Bin Chen, Juncheng Wang, Dandan Hu, Zhong-Guo Zhou, Li Xu, Minshan Chen, Yao-Jun Zhang
A risk-based post-resection follow-up strategy for hepatocellular carcinoma patients. Cancer (2022)
Jiongliang Wang, Zhikai Zheng, Tianqing Wu, Wenxuan Li, Juncheng Wang, Yang-Xun Pan, Wei Peng, Dandan Hu, Jiajie Hou, Li Xu, Yao-Jun Zhang, Minshan Chen, Rongxin Zhang, Zhongguo Zhou
Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study. Journal of hepatocellular carcinoma 9 (2022)
Yizhen Fu, Xia Li, Zhenyun Yang, Shaoqiang Li, Yang-Xun Pan, Jin-Bin Chen, Juncheng Wang, Dandan Hu, Zhong-Guo Zhou, Li Xu, Minshan Chen, Yao-Jun Zhang
A risk-based postresection follow-up strategy for hepatocellular carcinoma patients. Cancer 129 (4) (2022)
Qi-Jiong Li, Min-Ke He, Huan-Wei Chen, Wan-Qiang Fang, Yuan-Min Zhou, Li Xu, Wei Wei, Yao-Jun Zhang, Ying Guo, Rong-Ping Guo, Min-Shan Chen, Ming Shi
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Shu-Kui Qin, Feng Bi, Shanzhi Gu, Yuxian Bai, Zhendong Chen, Zishu Wang, Jieer Ying, Yinying Lu, Zhiqiang Meng, Hongming Pan, Ping Yang, Helong Zhang, Xi Chen, Aibing Xu, Chengxu Cui, Bo Zhu, Jian Wu, Xiaoli Xin, Jufeng Wang, Jinlu Shan, Junhui Chen, Zhendong Zheng, Li Xu, Xiaoyu Wen, Zhenyu You, Zhenggang Ren, Xiufeng Liu, Meng Qiu, Liqing Wu, Feng Chen
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (27) (2021)
Jian-Ming Xu, Jie Shen, Shanzhi Gu, Yun Zhang, Lihua Wu, Jian Wu, Guoliang Shao, Yanqiao Zhang, Li Xu, Tao Yin, Jingfeng Liu, Zhenggang Ren, Jianping Xiong, Xianhai Mao, Ling Zhang, Jiayin Yang, Lequn Li, Xiaoming Chen, Zhiming Wang, Kangsheng Gu, Xi Chen, Zhanyu Pan, Kuansheng Ma, Xinmin Zhou, Zujiang Yu, Enxiao Li, Guowen Yin, Xiao Zhang, Shuni Wang, Quanren Wang
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (4) (2020)
Wen Sun, Shi-Chao Li, Li Xu, Wei Zhong, Zhen-Guang Wang, Chu-Zhi Pan, Jing Li, Guang-Zhi Jin, Na Ta, Wei Dong, Dan Liu, Hui Liu, Hong-Yang Wang, Jin Ding
High FLT3 Levels May Predict Sorafenib Benefit in Hepatocellular Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (16) (2020)
Xuqi Sun, Dandan Hu, Zhoutian Yang, Zheng Liu, Juncheng Wang, Jin-Bin Chen, Li Xu, Zhongguo Zhou, Minshan Chen, Yao-Jun Zhang
Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy. Journal of hepatocellular carcinoma 7 (2020)
Zhong-Guo Zhou, Jin-Bin Chen, Rong-Xin Zhang, Ling Ye, Jun-Cheng Wang, Yang-Xun Pan, Xiao-Hui Wang, Wen-Xuan Li, Yao-Jun Zhang, Li Xu, Min-Shan Chen
Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients. Cancer communications (London, England) 40 (8) (2020)
Yuhao Tang, Xiaowei Sun, Li Xu
A slowly-growing solitary skip lymph nodule of occult gastric cancer above the neck of pancreas: a case report. Surgical case reports 6 (1) (2020)
Xuqi Sun, Dandan Hu, Yao-Jun Zhang, Ning Lyu, Li Xu, Qifeng Chen, Jinfa Lai, Minshan Chen, Ming Zhao
Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients? Journal of hepatocellular carcinoma 7 (2020)
Yang-Xun Pan, Mian Xi, Yi-Zhen Fu, Dan-Dan Hu, Jun-Cheng Wang, Shi-Liang Liu, Jin-Bin Chen, Li Xu, Zhong-Guo Zhou, Meng-Zhong Liu, Min-Shan Chen, Lei Zhao, Yao-Jun Zhang
Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study. Cancers 11 (8) (2019)